A new study from the UT Southwestern Simmons Comprehensive Cancer Center demonstrates that antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50% in patients with a history of liver cancer.
Aug 9, 2019
0
49
(HealthDay)—The incidence of Parkinson disease (PD) is lower for patients with chronic hepatitis C virus (HCV) infection who receive interferon-based antiviral therapy, according to a study published online June 5 in JAMA ...
Jun 6, 2019
0
2
A discovery of how stem cells are protected from viruses could inform the development of therapies for use in medicine, research suggests.
May 14, 2019
0
19
Australian doctors are prescribing antivirals for people with the flu who may not benefit, putting patients at risk of unnecessary side effects and potentially increasing the risk of antimicrobial resistance to these medications, ...
May 8, 2019
0
0
Structure-based drug design revealed that a compound previously investigated for the treatment of head-and-neck cancer could function as a lead compound for the development of drugs to treat hepatitis A virus infection, according ...
Apr 30, 2019
0
29
Dear Mayo Clinic: I have had a few cold sore flare-ups over the past few months after years without getting any. What causes them to come back, and what's the best way to treat them?
Apr 22, 2019
0
1
New research sheds light on how a hepatitis B viral protein stimulates the expansion of immune cells that impair antiviral responses, according to a study published April 18 in the open-access journal PLOS Pathogens by Haitao ...
Apr 18, 2019
0
62
Hepatitis C virus (HCV) is a hepatotropic virus, with about 80 million chronic infections confirmed worldwide. HCV infection leads to the development of chronic hepatitis, cirrhosis, and in some instances, hepatocellular ...
Apr 10, 2019
0
0
Nine patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving heart transplants from deceased donors who were infected with the disease, according to a study published in the American ...
Feb 25, 2019
0
164
The first prospective, longitudinal study investigating treatment of chronic hepatitis C with direct-acting antivirals finds that the treatment is associated with reduced risk of mortality and liver cancer, according to a ...
Feb 12, 2019
0
8
